0001213900-20-017809.txt : 20200717
0001213900-20-017809.hdr.sgml : 20200717
20200717163323
ACCESSION NUMBER: 0001213900-20-017809
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200715
FILED AS OF DATE: 20200717
DATE AS OF CHANGE: 20200717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hayes William B
CENTRAL INDEX KEY: 0001320940
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37521
FILM NUMBER: 201034093
MAIL ADDRESS:
STREET 1: 231 MAPLE AVENUE
CITY: BURLINGTON
STATE: NC
ZIP: 27215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intec Pharma Ltd.
CENTRAL INDEX KEY: 0001638381
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12 HARTOM STREET
STREET 2: HAR HOTZVIM
CITY: JERUSALEM
STATE: L3
ZIP: 777512
BUSINESS PHONE: 97225864657
MAIL ADDRESS:
STREET 1: 12 HARTOM STREET
STREET 2: HAR HOTZVIM
CITY: JERUSALEM
STATE: L3
ZIP: 777512
4
1
ownership.xml
X0306
4
2020-07-15
0
0001638381
Intec Pharma Ltd.
NTEC
0001320940
Hayes William B
C/O INTEC PHARMA LTD.
12 HARTOM STREET
JERUSALEM
L3
9777512
ISRAEL
1
0
0
0
Stock Option (right to buy)
0.3075
2020-07-15
4
A
0
40000
0
A
2027-07-15
Ordinary Shares
40000
40000
D
The stock option vests and becomes exercisable as to one-third of the total shares on July 15, 2021 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through July 15, 2023.
/s/ William B Hayes
2020-07-17